Growth and Development of Craniofacial Structures in Patients at Different Ages With Unrepaired Submucous Cleft

Congcong Cao1, Xue Xu2, Qian Zheng3

  • 1Resident, Department of Oral and Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

Insights

Submucous cleft palate (SMCP) is linked to craniofacial differences, including a smaller maxilla and jaw issues, which worsen with age. These findings highlight progressive maxillary retrognathism in SMCP patients.

Area of Science:

  • Craniofacial morphology
  • Pediatric dentistry
  • Orthodontics

Background:

  • Submucous cleft palate (SMCP) is a rare subtype of cleft palate.
  • Research on the craniofacial characteristics of SMCP patients is limited.
  • Understanding these features is crucial for diagnosis and treatment.

Purpose of the Study:

  • To conduct a cephalometric comparison of craniofacial features in SMCP patients versus non-cleft controls.
  • To analyze these features across different age groups (5-7, 9-11, and 18-30 years).

Main Methods:

  • Cross-sectional study comparing 60 SMCP patients with 60 non-cleft controls.
  • Cephalometric analysis of craniofacial measurements including cranial base, maxillary, and mandibular dimensions.
  • Statistical comparison using generalized linear models adjusted for age and gender.

Main Results:

  • Younger SMCP patients (5-7 years) exhibited shortened cranial base, maxillary length/height, and pharyngeal depth.
  • Older SMCP patients (9-11 and 18-30 years) showed reduced maxillary sagittal length, and an inharmonious jaw relationship.
  • Progressive maxillary retrognathism and reduced facial convexity were observed in SMCP patients from childhood to adulthood.

Conclusions:

  • Submucous cleft palate is associated with significant craniofacial alterations.
  • These alterations, particularly maxillary retrognathism, progress with age.
  • Cephalometric analysis provides valuable insights into SMCP-related craniofacial development.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
241
Fruit Development, Structure, and Function01:58

Fruit Development, Structure, and Function

Fruits form from a mature flower ovary. As seeds develop from the ovules contained within, the ovary wall undergoes a series of complex changes to form fruit. In some fruits, such as soybeans, the ovary wall dries; in other fruits, such as grapes, it remains fleshy. In some cases, organs other than the ovary contribute to fruit formation; such fruits are called accessory fruits.
25.4K
Seed Structure and Early Development of the Sporophyte02:33

Seed Structure and Early Development of the Sporophyte

Seed structures are composed of a protective seed coat surrounding a plant embryo, and a food store for the developing embryo. The embryo contains the precursor tissues for leaves, stem, and roots. The endosperm and cotyledons—seed leaves—act as the food reserves for the growing embryo.
31.3K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
713
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
264
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
223